Companies /Healthcare

AMGEN Inc

NASDAQ: AMGN Drug Manufacturers - General
$466.01
▲ $5.28 (+1.15%) today
Markets closed · 11:56pm ET

AMGN Coverage Page 48

3:18pm ET
Investing

A Modest Quarter For Amgen (AMGN)

Wall St. expected Amgen (AMGN) to report a 1% decline in earnings to $1.03 a share on a 1% decline in revenue to $3.56 billion for the third quarter, according to analysts…

Douglas A. McIntyre
3:09am ET
Media

Media Digest 10/24/2007

According to Reuters, shares in Amazon (AMZN) dropped on concerns about margins in it latest earnings. Reuters writes that RIM (RIMM) will start to market its Blackberry in China. Reuters reports that…

Douglas A. McIntyre
7:55am ET
Investing

Nasdaq Short Interest (LVLT)(MSFT)(SIRI)(INTC)

Below is the short interest for selected stocks traded on the Nasdaq. The figures are as of September 28 and compare to numbers as of September 14, 2007. Largest Short Positions Company …

Douglas A. McIntyre
7:25am ET
Health and Healthcare

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday’s decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels in kidney-failure…

Douglas A. McIntyre
7:35am ET
Investing

Pre-Market Stock News (August 16, 2007)

(AMGN) Amgen announced 12-14% layoffs and lowered guidance for 2007.(ANX) ADVENTRX Pharma announces fast track designation granted by the FDA for CoFactor for treatment of metastatic colorectal cancer.(AUXL) Auxilium Pharma receivef FDA…

Douglas A. McIntyre